EGFR and non-small cell lung carcinoma: The enrichment analysis revealed a highly significant positive correlation with the regulation of signal transduction (GO-term) and EGFR TKI resistance, different solid cancer types, namely pancreatic, prostate, and NSCLC as well as ErbB and HIF-1 signaling (KEGG pathway, Supplemental Tables S6 and S7).